Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yanae is a non-hormonal copper intrauterine device (IUD) developed by 49Care for long-term contraception. The device is a T-shaped Cu 380 model that provides protection for up to 5 years by releasing copper ions into the uterine cavity. These ions create a spermicidal environment and induce a local inflammatory response that prevents fertilization. A key feature of Yanae is its CrossGlide inserter, which utilizes inflatable membrane technology to self-navigate the cervical canal, aiming to provide a gentle, atraumatic insertion without the need for traditional instruments like tenaculum forceps. It is available in standard and mini sizes and was launched in Canada in January 2025.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yanae.